LARONIDASE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Fri Dec 15 15:34:20 GMT 2023` Edited by `admin` on `Fri Dec 15 15:34:20 GMT 2023`
Protein Type	ENZYME
Protein Sub Type	IDURONIDASE
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	WP58SVM6R4
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

LARONIDASE

Official Name

English

IDURONIDASE, .ALPHA.-L-(8-HISTIDINE) (HUMAN)

Common Name

English

ALRONIDASE

Common Name

English

LARONIDASE [PURPLE BOOK CDER]

Common Name

English

LARONIDASE [JAN]

Common Name

English

ALDURAZYME

Brand Name

English

EC 3.2.1.76

Common Name

English

LARONIDASE [MI]

Common Name

English

Laronidase [WHO-DD]

Common Name

English

IDURONIDASE, ALPHA-L- (HOMO SAPIENS)

Common Name

English

LARONIDASE [EMA EPAR]

Common Name

English

laronidase [INN]

Common Name

English

LARONIDASE [USAN]

Common Name

English

LARONIDASE [MART.]

Common Name

English

LARONIDASE [VANDF]

Common Name

English

Classification Tree Code System Code

NDF-RT

N0000167711

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

NDF-RT

N0000175823

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

WHO-ATC

A16AB05

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

WHO-VATC

QA16AB05

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

EMA ASSESSMENT REPORTS

ALDURAZYME (AUTHOURIZED: MUCOPOLYSACCHARIDOSIS I)

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

EU-Orphan Drug

EU/3/01/022

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

FDA ORPHAN DRUG

106097

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

NCI_THESAURUS

C29726

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

Code System Code Type Description

USAN

LL-41

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

EVMPD

SUB20048

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

SMS_ID

100000089543

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

DRUG BANK

DB00090

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

MERCK INDEX

m6205

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

Merck Index

DAILYMED

WP58SVM6R4

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

DRUG CENTRAL

4997

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

RXCUI

392509

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

RxNorm

CAS

210589-09-6

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

WIKIPEDIA

Iduronidase

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

INN

8015

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

LACTMED

Laronidase

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

FDA UNII

WP58SVM6R4

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

NCI_THESAURUS

C83864

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

ChEMBL

CHEMBL1201595

Created by admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023

PRIMARY

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_85
N	1_165
N	1_311
N	1_357
N	1_390
N	1_426

Related Record Type Details


					WP58SVM6R4

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL
Volume of Distribution	PHARMACOKINETIC

Biological Half-life	PHARMACOKINETIC

Molecular Formula	CHEMICAL